DOI:
10.1055/s-00034916
Nervenheilkunde
LinksClose Window
References
Hadden RDM, Marreno F..
Switch from intravenous to subcutaneous immunoglobulin in CIDP and MMN: improved tolerability and patient satisfaction.
Ther Adv Neurol Disord 2015;
8: 14-9 doi:10.1177/1756285614563056
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.